![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Agulnik Mark Siu Lillian L
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.7, Iss.4, 2006-03, pp. : 489-494
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chemotherapy in head and neck cancer
Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for head and neck cancer
By Rhee John C Khuri Fadlo R Shin Dong M
Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Improving management of head and neck cancer
Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. :